Insmed, Inc. (INSM) Reports Q3 Loss of $1.39, Sales Fall Y/Y
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $110.17 +5.49%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Insmed, Inc. (NASDAQ: INSM) reported Q3 EPS of ($1.39), versus ($0.03) reported last year. Revenue for the quarter came in at $400 thousand, versus $1.8 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Insmed (INSM) PT Lowered to $201 at Guggenheim
- L.B. Foster (FSTR) Reports In-Line Q3 EPS ; Offers Guidance
- Flutter Entertainment plc (FLUT) Misses Q3 EPS by 525c; lowers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
